Back to News
Market Impact: 0.65

Here are the 4 big things we're watching in the stock market in the week ahead

BLKWFCGSCOFNKEBAMSABTCRMFASTDPZJNJJPMCACIERICHWCASMLBACSYFPLDPNCCZFSFHNJBHTUALSLGSNVHOMBBKMMCSCHWTRVUSBKEYSNAMTBTSMCSXIBKROZKLBRTTFCAXPFITBHBANSLBRFSTTCMAALLY
Corporate EarningsCorporate Guidance & OutlookTrade Policy & Supply ChainTax & TariffsArtificial IntelligenceEconomic DataBanking & LiquidityElections & Domestic Politics
Here are the 4 big things we're watching in the stock market in the week ahead

The upcoming week kicks off earnings season with key reports from major financials including BlackRock, Wells Fargo, and Goldman Sachs, alongside Abbott Laboratories, where investors will focus on organic growth, capital returns, and investment banking performance, respectively. This earnings backdrop is complicated by escalating U.S.-China trade tensions, following President Trump's new tariff threats, and a prolonged government shutdown now causing layoffs and delaying critical economic data, notably the CPI report. Additionally, Salesforce's Dreamforce conference will be closely watched for insights into how AI is impacting its enterprise software business model.

Analysis

The upcoming earnings season commences amidst a moderately negative market sentiment, primarily driven by escalating U.S.-China trade tensions and a prolonged government shutdown. President Trump's threat of 100% additional tariffs on Chinese imports, coupled with the shutdown leading to federal worker layoffs and delayed economic data like the CPI report, introduces significant macro uncertainty and market volatility. Key financial institutions BlackRock (BLK), Wells Fargo (WFC), and Goldman Sachs (GS) are set to report. BlackRock is anticipated to show 7% organic base fee growth and constructive forward margin expansion, despite past disappointments in net asset flows. Wells Fargo's report will be scrutinized for capital return plans and net interest margin (NIM) guidance, particularly following a downgrade citing concerns over NIM contraction. Goldman Sachs is expected to deliver robust investment banking fee growth, with consensus at 15.4% year-over-year, benefiting from M&A and IPO activity, alongside strong trading desk performance. Separately, Abbott Laboratories (ABT) faces pressure to demonstrate recovery in its China diagnostics segment and continued momentum in medical devices, while Salesforce (CRM) will use its Dreamforce conference to address the impact of AI on its business model and client value proposition.

AllMind AI Terminal